These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25140629)

  • 1. ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent.
    Chang JY; Kestin LL; Barriger RB; Chetty IJ; Ginsburg ME; Kumar S; Loo BW; Movsas B; Rimner A; Rosenzweig KE; Stinchcombe TE; Videtic GM; Willers H
    Oncology (Williston Park); 2014 Aug; 28(8):706-10, 712, 714 passim. PubMed ID: 25140629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent.
    Rosenzweig KE; Chang JY; Chetty IJ; Decker RH; Ginsburg ME; Kestin LL; Kong FM; Lally BE; Langer CJ; Movsas B; Videtic GM; Willers H
    J Am Coll Radiol; 2013 Sep; 10(9):654-64. PubMed ID: 23890874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACR Appropriateness Criteria(®) induction and adjuvant therapy for N2 non-small-cell lung cancer.
    Willers H; Stinchcombe TE; Barriger RB; Chetty IJ; Ginsburg ME; Kestin LL; Kumar S; Loo BW; Movsas B; Rimner A; Rosenzweig KE; Videtic GM; Chang JY;
    Am J Clin Oncol; 2015 Apr; 38(2):197-205. PubMed ID: 25803563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACR appropriateness Criteria® early-stage non-small-cell lung cancer.
    Videtic GM; Chang JY; Chetty IJ; Ginsburg ME; Kestin LL; Kong FM; Lally BE; Loo BW; Movsas B; Stinchcombe TE; Willers H; Rosenzweig KE;
    Am J Clin Oncol; 2014 Apr; 37(2):201-7. PubMed ID: 25180631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACR Appropriateness Criteria: nonsurgical treatment for non-small-cell lung cancer: good performance status/definitive intent.
    Gewanter RM; Rosenzweig KE; Chang JY; Decker R; Dubey S; Kong FM; Lally BE; Langer CJ; Lee HK; Movsas B
    Curr Probl Cancer; 2010; 34(3):228-49. PubMed ID: 20541060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACR Appropriateness Criteria® radiation therapy for small-cell lung cancer.
    Kong FM; Lally BE; Chang JY; Chetty IJ; Decker RH; Ginsburg ME; Kestin LL; Langer CJ; Movsas B; Videtic GM; Willers H; Rosenzweig KE;
    Am J Clin Oncol; 2013 Apr; 36(2):206-13. PubMed ID: 23511336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil.
    ; Yeung AR; Garg MK; Lawson J; McDonald MW; Quon H; Ridge JA; Saba N; Salama JK; Smith RV; Yom SS; Beitler JJ;
    Head Neck; 2012 May; 34(5):613-6. PubMed ID: 22250010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer.
    Moran BJ; DeRose P; Hsu IC; Abdel-Wahab M; Arterbery VE; Ciezki JP; Frank SJ; Mohler JL; Rosenthal SA; Rossi CJ; Yamada Y; Merrick GS
    Am J Clin Oncol; 2011 Dec; 34(6):636-47. PubMed ID: 22101389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer.
    Jolly S; Soni P; Gaffney DK; Biagioli M; Elshaikh MA; Jhingran A; Kidd E; Lee LJ; Li L; Moore DH; Rao GG; Wahl AO; Williams NL; Yashar CM; Small W
    Oncology (Williston Park); 2015 Nov; 29(11):867-72, 874-5. PubMed ID: 26568534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACR Appropriateness Criteria non-invasive clinical staging of bronchogenic carcinoma.
    Ravenel JG; Rosenzweig KE; Kirsch J; Ginsburg ME; Kanne JP; Kestin LL; Parker JA; Rimner A; Saleh AG; Mohammed TL
    J Am Coll Radiol; 2014 Sep; 11(9):849-56. PubMed ID: 25086958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancer.
    Ridge JA; Lawson J; Yom SS; Garg MK; McDonald MW; Quon H; Saba N; Salama JK; Smith RV; Worden F; Yeung AR; Beitler JJ
    Head Neck; 2014 Jan; 36(1):3-8. PubMed ID: 23696520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acr appropriateness Criteria management of vaginal cancer.
    Lee LJ; Jhingran A; Kidd E; Cardenes HR; Elshaikh MA; Erickson B; Mayr NA; Moore D; Puthawala AA; Rao GG; Small W; Varia MA; Wahl AO; Wolfson AH; Yashar CM; Yuh W; Gaffney DK
    Oncology (Williston Park); 2013 Nov; 27(11):1166-73. PubMed ID: 24575547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American College of Radiology Appropriateness Criteria(®)--locally advanced (high-risk) prostate cancer.
    Ciezki JP; Hsu IC; Abdel-Wahab M; Arterbery VE; Frank SJ; Mohler JL; Moran BJ; Rosenthal SA; Rossi CJ; Yamada Y; Merrick G;
    Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):43-51. PubMed ID: 21875782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACR appropriateness criteria® locally advanced breast cancer.
    Macdonald SM; Harris EE; Arthur DW; Bailey L; Bellon JR; Carey L; Goyal S; Halyard MY; Horst KC; Moran MS; Haffty BG
    Breast J; 2011; 17(6):579-85. PubMed ID: 21906206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
    Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG
    J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer.
    Gustafson GS; Nguyen PL; Assimos DG; D'Amico AV; Gottschalk AR; Hsu IC; Lloyd S; Mclaughlin PW; Merrick GS; Showalter TN; Taira AV; Vapiwala N; Yamada Y; Davis BJ
    Oncology (Williston Park); 2014 Dec; 28(12):1125-30, 1132-6. PubMed ID: 25510812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How can we optimise concurrent chemoradiotherapy for inoperable stage III non-small cell lung cancer?
    Bayman N; Blackhall F; McCloskey P; Taylor P; Faivre-Finn C
    Lung Cancer; 2014 Feb; 83(2):117-25. PubMed ID: 24373738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancer.
    Wolfson AH; Varia MA; Moore D; Rao GG; Gaffney DK; Erickson-Wittmann BA; Jhingran A; Mayr NA; Puthawala AA; Small W; Yashar CM; Yuh W; Cardenes HR;
    Gynecol Oncol; 2012 Apr; 125(1):256-62. PubMed ID: 22155418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancer.
    Small W; Strauss JB; Jhingran A; Yashar CM; Cardenes HR; Erickson-Wittmann BA; Gullett N; Kidd E; Lee LJ; Mayr NA; Moore D; Puthawala AA; Rao GG; Varia MA; Wahl AO; Wolfson AH; Yuh W; Gaffney DK
    Am J Clin Oncol; 2012 Aug; 35(4):399-405. PubMed ID: 22810416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.